Breadcrumb

What's New at the RI-MUHC ?

Paving the way for COVID-19 research

RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2

Stem cells are the marrow of the TB pandemic, which still kills one person every 22 seconds

A new study finds that not only can stem cells be targeted for protective vaccination, but they can also ...

Recovering from sleep deprivation: What is the role of astrocytes?

A new RI-MUHC study uses sleep-deprived fruit flies to study regulation of rebound sleep

Understanding the psychological trauma related to facial transplantation

Dr. Mirko Gilardino is co-author of study that examines issues around patients’ consent

Gene therapy to restore sight coming to the Montreal Children's Hospital and to Quebec

Dozens of young patients will be among the first in Canada to benefit from this treatment, which improves vision...

Supporting those grieving requires “literacy,” researcher Mary Ellen Macdonald suggests

Grief amidst the pandemic is an increasing reality in communities worldwide

Spike in peanut and nut anaphylaxis in children at Halloween and Easter

New study suggests education and awareness are needed to help reduce risk of anaphylaxis at specific times of the year

Sleep apnea treatment reduces heart problems in patients with prediabetes, a new study finds

People with prediabetes and obstructive sleep apnea could reduce their daytime resting heart rate and risk of cardiovascular disease by using a CPAP machine at night

Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

Learn more about the RI-MUHC